Compare Inovio Pharmaceuticals Inc (INO) vs Royal Bank of Canada (RY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Royal Bank of Canada — how do they compare? Inovio Pharmaceuticals Inc trades at $0.8 (market cap $78.55M), while Royal Bank of Canada trades at $210.44 (market cap $292.32B). The key difference: Royal Bank of Canada is far larger — about 3721.5× Inovio Pharmaceuticals Inc's market cap, and Royal Bank of Canada pays a 2.37% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | RY | |
|---|---|---|
Market Cap | $78.55M | $292.32B |
Sector | Health | Financials |
52-Week High | $2.87 | $217.87 |
52-Week Low | $0.66 | $134.80 |
Enterprise Value | $49.56M | — |
Dividend Yield | — | 2.37% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Royal Bank of Canada
Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.
Read more on RY →
